MARCUS SIKORSKI: Open Payments
NPI 1700869575 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 13 payments from 10 companies in 2025. Trend: 2023 $1,483 · 2024 $2,177 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $300 |
| Janssen Biotech, Inc. | 2 | $251 |
| E.R. Squibb & Sons, L.L.C. | 2 | $159 |
| Intera Oncology, Inc | 1 | $145 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Syndax Pharmaceuticals, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Iovance Biotherapeutics, Inc. | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 1 | $81 |
Products named: RYBREVANT, MONOFERRIC, COSELA, INTERA, ZEPZELCA, OJJAARA, REVUFORJ, Amtagvi.
Industry payments across NY — which companies pay providers there.
